Surrozen (SRZN) EBT Margin (2024 - 2026)
Surrozen (SRZN) posted quarterly EBT Margin of 650.04% for Q1 2026, up 81029.0% year-over-year from N/an in Q1 2025, and up 62.08% quarter-over-quarter from 1714.2% in Q4 2025.
Powered by 
Analysis
Surrozen (SRZN) EBT Margin (2024 - 2026) Analysis & Trends
Surrozen's EBT Margin history runs 3 years deep, the most recent figure standing at 650.04% for Q1 2026.
- In Q1 2026, EBT Margin rose 81029.0% year-over-year to 650.04%; the TTM figure through Mar 2026 stood at 1021.96% (down 29034.0% YoY), while the FY2025 annual figure was 1493.64%, down 78279.0% from the prior year.
- EBT Margin for Q1 2026 stood at 650.04%, up from 1714.2% in the prior quarter.
- The five-year high for EBT Margin was 1.04% in Q3 2024, with the low at 9175.73% in Q4 2024.
- The 3-year median for EBT Margin is 1710.68% (2025), against an average of 2366.16%.
- Peak annual rise in EBT Margin reached 746152 bps in 2025, while the deepest fall reached 185424 bps in 2025.
- Surrozen's EBT Margin stood at 9175.73% in 2024, then surged by 81 bps to 1714.2% in 2025, then soared by 62 bps to 650.04% in 2026.
- Business Quant data shows SRZN's EBT Margin at 650.04% in Q1 2026, 1714.2% in Q4 2025, and 1853.2% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Surrozen | 263.35 Mn | 263.35 Mn | - | -188.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -188.64% |
| Mar 31, 2026 | -190.88% |
| Dec 31, 2025 | -2,244.51% |
| Sep 30, 2025 | -1,014.65% |
| Jun 30, 2025 | -813.02% |
| Mar 31, 2025 | -941.51% |
| Dec 31, 2024 | -1,252.67% |
| Sep 30, 2024 | 16.63% |